[Statlist] Final announcement: BBS seminar "AI in Clinical Research and Drug Development and BBS General Assembly" on September 25, 2024, from 13:00-17:45h CET

[Blatna, Bibiana]

Dear BBS colleagues,

Please follow the link to the final announcement, including an updated PROGRAM<https://baselbiometrics.github.io/home/docs/upcoming/20240925/agenda.pdf> and speaker bio-sketches.
Please join our exciting BBS event on " AI in Clinical Research and Drug Development and BBS General Assembly" on September 25, 2024 (13:00-17:45h CET),  either onsite (D-BSSE; ETH in Basel) or virtual. Participation is free of charge, but REGISTRATION<https://docs.google.com/forms/d/e/1FAIpQLSfrMLarUZAurr3UR7lKjckB-4UNbJAYZih3W0FQ5onrqRcrzg/viewform> is mandatory.

The application of artificial intelligence (AI) has generated significant excitement due to its potential to automate processes and extract valuable insights from complex datasets. This seminar offers an introduction to AI methodologies, a discussion of the benefits and limitations of AI solutions, and a series of informative case studies. The program features eminent statisticians, data scientists, and medical doctors from academia, pharmaceutical companies, university hospitals, and regulatory agencies.

Best Regards,
Organizing committee:
Marcel Wolbers (Roche), Jenny Devenport (Roche), Dominik Heinzmann (Roche), Kristina Weber (Roche), Lilla Di Scala (Johnson & Johnson), Marco Cattaneo (University Hospital Basel), Andreas Ziegler (Cardio-CARE Davos), Jack Kuipers (ETH Zurich - D-BSSE), Giusi Moffa (University Basel) on behalf of the BBS.

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mailman.stat.ch/pipermail/statlist/attachments/20240909/b4b4bc86/attachment.htm>